Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct;35(3):333-349.
doi: 10.1016/j.bpa.2020.12.002. Epub 2020 Dec 8.

Clinical recommendations for in-hospital airway management during aerosol-transmitting procedures in the setting of a viral pandemic

Affiliations
Review

Clinical recommendations for in-hospital airway management during aerosol-transmitting procedures in the setting of a viral pandemic

Alexander Fuchs et al. Best Pract Res Clin Anaesthesiol. 2021 Oct.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can lead to severe pneumonia and multiorgan failure. While most of the infected patients develop no or only mild symptoms, some need respiratory support or even invasive ventilation. The exact route of transmission is currently under investigation. While droplet exposure and direct contact seem to be the most significant ways of transmitting the disease, aerosol transmission appears to be possible under circumstances favored by high viral load. Despite the use of personal protective equipment (PPE), this situation potentially puts healthcare workers at risk of infection, especially if they are involved in airway management. Various recommendations and international guidelines aim to protect healthcare workers, although evidence-based research confirming the benefits of these approaches is still scarce. In this article, we summarize the current literature and recommendations for airway management of COVID-19 patients.

Keywords: COVID-19; aerosol-transmitted viral diseases; airway management; critical care; intubation; narrative review.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest This research did not receive specific support from funding agencies in the public, commercial, or not-for-profit sectors. Richard D. Urman reports research funding/fees from Merck, Medtronic/Covidien, AcelRx, Takeda, Pfizer. All other authors declare no conflicts of interest.

References

    1. WHO coronavirus disease (COVID-19) dashboard. World Health Organization; Geneva: 2020. https://covid19.who.int/ Available online: Last viewed 11.24.2020. 2020.
    1. Lotfi M., Hamblin M.R., Rezaei N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020;508:254–266. doi: 10.1016/j.cca.2020.05.044. - DOI - PMC - PubMed
    1. Fennelly K.P. Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med. 2020;8(9):914–924. doi: 10.1016/s2213-2600(20)30323-4. - DOI - PMC - PubMed
    1. Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis. 2006;12(11):1657–1662. doi: 10.3201/eid1211.060426. - DOI - PMC - PubMed
    1. Judson S.D., Munster V.J. Nosocomial transmission of emerging viruses via aerosol-generating medical procedures. Viruses. 2019;11(10) doi: 10.3390/v11100940. - DOI - PMC - PubMed

MeSH terms